Identification of a Putative Mitochondrial Solute Carrier that Regulates Mitophagy
Project Number1F31NS134242-01A1
Former Number1F31NS134242-01
Contact PI/Project LeaderRESTREPO, LUCAS JOHN
Awardee OrganizationUNIV OF MASSACHUSETTS MED SCH WORCESTER
Description
Abstract Text
ABSTRACT
Mitochondria are essential for cell health and survival. Understanding the quality control machinery that
mitochondria employ to maintain a healthy network is critical for health and disease. Our lab recently showed
the role that lipid transfer protein Vps13D plays a critical role in mitochondrial clearance by autophagy (mitophagy)
in the Drosophila developing midgut. Vps13D has been implicated in human movement disorders, highlighting
the importance of understanding how it controls this process. Importantly, we do not know what proteins Vps13D
may be interacting with at the mitochondrial surface to facilitate mitophagy. I performed an RNAi screen against
mitochondrial genes that were shown to physically interact with Vps13D in human cells. I discovered that Mtch,
the fly homolog of MTCH2, phenocopies both mitochondrial and autophagic defects that Vps13D mutants display,
including failure to clear mitochondria, autophagic cargoes like p62, and the autophagy protein Atg8a. I
generated a null mutant for Mtch, which displays phenotypes similar to what is observed by Mtch knockdown
with RNAi and Vps13D mutants. Importantly, Mtch mutant cells exhibit a robust decrease in Vps13D protein
puncta. I plan to use this Mtch mutant to: (1) characterize the function of Mtch in mitophagy, (2) determine the
relationship between Mtch and Vps13D in mitophagy, and (3) investigate the relationship between Mtch and
known regulators of autophagy and mitophagy. These studies will advance the field by creating a better
understanding of mitophagy, and will also provide a novel genetic pathway to study that could lead to targeted
therapies to correct mitochondrial disorders.
Public Health Relevance Statement
Project Narrative
Mitochondrial-selective autophagy (mitophagy) is an essential cellular process needed to promote cell survival,
but the genes that play a role in this process are not well understood. I am studying a novel regulator of
mitophagy at the mitochondrial surface that physically interacts with lipid transport protein VPS13D, a gene
implicated in age-associated movement disorders that regulates mitochondrial clearance. Studying this process
will benefit our overall understanding of mitophagy, and provide novel insight into therapeutics to combat
defective mitophagy diseases like Parkinson’s disease.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AffectAgingAntibodiesAreaAtaxiaAutophagocytosisAutophagosomeBiochemical PathwayCRISPR/Cas technologyCarrier ProteinsCell PhysiologyCell SurvivalCellsDefectDevelopmentDiseaseDrosophila genusEndoplasmic ReticulumExhibitsFailureFamilyGenesGeneticHealthHomologous GeneHumanLeadLysosomesMediatorMembrane ProteinsMetabolicMetabolismMidgutMitochondriaMitochondrial DiseasesMorphologyMotor Neuron DiseaseMovement DisordersMutationOrganellesPINK1 geneParkinParkinson DiseasePathway interactionsPhenocopyPhenotypePlayProcessProteinsProteomicsQuality ControlRNA InterferenceRNA interference screenRoleSiteSpastic ParaplegiaSurfaceTherapeuticTransmission Electron MicroscopyVacuolar Protein SortingVesicleage relatedcombatcomparison controlearly onsetflyimmunocytochemistryinsightknock-downknockout genelipid biosynthesislipid transfer proteinlipid transportloss of functionmembermetabolomicsmitochondrial autophagymitochondrial membranemutantnovelpreventsolutespasticitytargeted treatment
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
603847393
UEI
MQE2JHHJW9Q8
Project Start Date
01-July-2024
Project End Date
31-May-2027
Budget Start Date
01-July-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$33,758
Direct Costs
$33,758
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Neurological Disorders and Stroke
$33,758
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1F31NS134242-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1F31NS134242-01A1
Patents
No Patents information available for 1F31NS134242-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1F31NS134242-01A1
Clinical Studies
No Clinical Studies information available for 1F31NS134242-01A1
News and More
Related News Releases
No news release information available for 1F31NS134242-01A1
History
No Historical information available for 1F31NS134242-01A1
Similar Projects
No Similar Projects information available for 1F31NS134242-01A1